South and Central America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Report Overview

Table of Contents

1596.68

Select License Type

£1,596.68	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£3,193.35	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£4,790.03	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£1,596.68	Add to Wishlist
Change Currency	GBP EURO USD
	Order By Fax

Market	Healthcare and Medical
Report Type	Market Research
Country	South America
Published	30 September 2009
Number of Pages	116
Report Delivery	Email
Delivery Lead Time	-
Publisher	Global Markets Direct
File Format	-

South and Central America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to South & Central America In vitro diagnostics market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in South & Central America.

Scope

- The report provides information on the South and Central American in vitro diagnostics market, broken down into detailed categories and segments including In Vitro Diagnostics Devices, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.
- Market shares of all the key competitors including F. Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., and Siemens Medical Solutions, amongst others.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the in vitro diagnostics devices market in South and Central America.
- Evaluate and compare the attractiveness of the market in the region.
- Identify growth segments and opportunities in each industry sector within the region.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region.
- Analyze the competitiveness of the market in the region and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the region.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the region.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£1,596.68	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£3,193.35	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£4,790.03	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£1,596.68	Add to Wishlist
Change Currency	GBP EURO USD

1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of Markets Covered in the Report 14
3.1 In Vitro Diagnostics 14
3.2 Clinical Chemistry 14
3.3 Genetic Testing 14
3.4 Haematology 14
3.5 Histology And Cytology 14
3.6 Immuno Chemistry 14
3.7 Infectious Immunology 14
3.8 Microbiology Culture 15
4 In Vitro Diagnostics in South and Central America 16
4.1 In Vitro Diagnostics, South and Central America, Overall Revenue ($ mn), 2000-2015 16
4.2 In Vitro Diagnostics, South and Central America, Company share (2007-2008) 22
5 In Vitro Diagnostics In Brazil 23
5.1 In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), 2000-2015 23
5.2 In Vitro Diagnostics, Brazil, Distribution Share (2007-2008) 28
5.2.1 Clinical Chemistry Distribution Share (2007-2008) 28
5.2.2 Genetic Testing Distribution Share (2007-2008) 28
5.2.3 Haematology Distribution Share (2007-2008) 29
5.2.4 Histology And Cytology Distribution Share (2007-2008) 29
5.2.5 Immuno Chemistry Distribution Share (2007-2008) 30
5.2.6 Infectious Immunology Distribution Share (2007-2008) 30
5.2.7 Microbiology Culture Distribution Share (2007-2008) 31
5.3 In Vitro Diagnostics, Brazil, Company Share (2007-2008) 32
5.3.1 In Vitro Diagnostics, Brazil, Company Share (2007-2008) 32
5.3.2 Clinical Chemistry, Brazil, Company Share (2007-2008) 33
5.3.3 Genetic Testing, Brazil, Company Share (2007-2008) 34
5.3.4 Haematology, Brazil, Company Share (2007-2008) 35
5.3.5 Histology And Cytology, Brazil, Company Share (2007-2008) 36
5.3.6 Immuno Chemistry, Brazil, Company Share (2007-2008) 37
5.3.7 Infectious Immunology, Brazil, Company Share (2007-2008) 39
5.3.8 Microbiology Culture, Brazil, Company Share (2007-2008) 41
6 In Vitro Diagnostics In Argentina 42
6.1 In Vitro Diagnostics, Argentina, Overall Revenue ($ mn), 2000-2015 42
6.2 In Vitro Diagnostics, Argentina, Distribution Share (2007-2008) 47
6.2.1 Clinical Chemistry Distribution Share (2007-2008) 47
6.2.2 Genetic Testing Distribution Share (2007-2008) 47
6.2.3 Haematology Distribution Share (2007-2008) 48
6.2.4 Histology And Cytology Distribution Share (2007-2008) 48
6.2.5 Immuno Chemistry Distribution Share (2007-2008) 49
6.2.6 Infectious Immunology Distribution Share (2007-2008) 49
6.2.7 Microbiology Culture Distribution Share (2007-2008) 50
6.3 In Vitro Diagnostics, Argentina, Company Share (2007-2008) 51
6.3.1 In Vitro Diagnostics, Argentina, Company Share (2007-2008) 51
6.3.2 Clinical Chemistry, Argentina, Company Share (2007-2008) 52
6.3.3 Genetic Testing, Argentina, Company Share (2007-2008) 53
6.3.4 Haematology, Argentina, Company Share (2007-2008) 54
6.3.5 Histology And Cytology, Argentina, Company Share (2007-2008) 55
6.3.6 Immuno Chemistry, Argentina, Company Share (2007-2008) 56
6.3.7 Infectious Immunology, Argentina, Company Share (2007-2008) 58
6.3.8 Microbiology Culture, Argentina, Company Share (2007-2008) 60
7 In Vitro Diagnostics In Mexico 61
7.1 In Vitro Diagnostics, Mexico, Overall Revenue ($ mn), 2000-2015 61
7.2 In Vitro Diagnostics, Mexico, Distribution Share (2007-2008) 62
7.2.1 Clinical Chemistry Distribution Share (2007-2008) 62
7.2.2 Genetic Testing Distribution Share (2007-2008) 62
7.2.3 Haematology Distribution Share (2007-2008) 63
7.2.4 Histology and Cytology Distribution Share (2007-2008) 63
7.2.5 Immuno Chemistry Distribution Share (2007-2008) 64
7.2.6 Infectious Immunology Distribution Share (2007-2008) 64
7.2.7 Microbiology Culture Distribution Share (2007-2008) 65
7.3 In Vitro Diagnostics, Mexico, Company Share (2007-2008) 66
7.3.1 In Vitro Diagnostics, Mexico, Company Share (2007-2008) 66
7.3.2 Clinical Chemistry, Mexico, Company Share (2007-2008) 67
7.3.3 Genetic Testing, Mexico, Company Share (2007-2008) 68
7.3.4 Haematology, Mexico, Company Share (2007-2008) 69
7.3.5 Histology and Cytology, Mexico, Company Share (2007-2008) 70
7.3.6 Immuno Chemistry, Mexico, Company Share (2007-2008) 71
7.3.7 Infectious Immunology, Mexico, Company Share (2007-2008) 73
7.3.8 Microbiology Culture, Mexico, Company Share (2007-2008) 75
8 Overview of Key Companies in In Vitro Diagnostics Market 76
8.1 Ventana Medical Systems, Inc. 76
8.1.1 Company Overview 76
8.2 Sysmex Corporation 76
8.2.1 Company Overview 76
8.2.2 Sysmex Corporation Pipeline Products 76
8.2.2.1 Sysmex Corporation Pipeline Products By Equipment Type 76
8.2.2.2 Sysmex Corporation Pipeline Products By Development Stage 76
8.2.2.3 Sysmex Corporation Pipeline Products By Therapy Area 77
8.2.2.4 Sysmex Corporation Pipeline Products By News Summary 77
8.3 Siemens Healthcare 78
8.3.1 Company Overview 78
8.4 Qiagen N.V. 78
8.4.1 Company Overview 78
8.4.2 Qiagen N.V. Pipeline Products 79
8.4.2.1 Qiagen N.V. Pipeline Products By Equipment Type 79
8.4.2.2 Qiagen N.V. Pipeline Products By Development Stage 79
8.4.2.3 Qiagen N.V. Pipeline Products By Therapy Area 80
8.4.2.4 Qiagen N.V. Pipeline Products By News Summary 80
8.5 Phadia AB 81
8.5.1 Company Overview 81
8.5.2 Phadia AB Pipeline Products 81
8.5.2.1 Phadia AB Pipeline Products By Equipment Type 81
8.5.2.2 Phadia AB Pipeline Products By Development Stage 81
8.5.2.3 Phadia AB Pipeline Products By Therapy Area 82
8.5.2.4 Phadia AB Pipeline Products By News Summary 82
8.6 Ortho-Clinical Diagnostics Inc. 83
8.6.1 Company Overview 83
8.6.2 Ortho-Clinical Diagnostics Inc. Pipeline Products 83
8.6.2.1 Ortho-Clinical Diagnostics Inc. Pipeline Products By Equipment Type 83
8.6.2.2 Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage 84
8.6.2.3 Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area 84
8.7 OLYMPUS CORPORATION 85
8.7.1 Company Overview 85
8.8 Inverness Medical Innovations, Inc. 85
8.8.1 Company Overview 85
8.8.2 Inverness Medical Innovations, Inc. Pipeline Products 86
8.8.2.1 Inverness Medical Innovations, Inc. Pipeline Products By Equipment Type 86
8.8.2.2 Inverness Medical Innovations, Inc. Pipeline Products By Development Stage 86
8.8.2.3 Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area 87
8.8.2.4 Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials 87
8.8.2.5 Inverness Medical Innovations, Inc. Pipeline Products By News Summary 87
8.9 Hologic, Inc. 88
8.9.1 Company Overview 88
8.9.2 Hologic, Inc. Pipeline Products 88
8.9.2.1 Hologic, Inc. Pipeline Products By Equipment Type 88
8.9.2.2 Hologic, Inc. Pipeline Products By Development Stage 89
8.9.2.3 Hologic, Inc. Pipeline Products By Therapy Area 89
8.9.2.4 Hologic, Inc. Pipeline Products By Clinical Trials 89
8.9.2.5 Hologic, Inc. Pipeline Products By News Summary 90
8.10 Gen-Probe Incorporated 91
8.10.1 Company Overview 91
8.10.2 Gen-Probe Incorporated Pipeline Products 91
8.10.2.1 Gen-Probe Incorporated Pipeline Products By Equipment Type 91
8.10.2.2 Gen-Probe Incorporated Pipeline Products By Development Stage 92
8.10.2.3 Gen-Probe Incorporated Pipeline Products By Therapy Area 92
8.10.2.4 Gen-Probe Incorporated Pipeline Products By Clinical Trials 92
8.10.2.5 Gen-Probe Incorporated Pipeline Products By News Summary 93
8.11 F. Hoffmann-La Roche Ltd. 94
8.11.1 Company Overview 94
8.12 DiaSorin S.p.A 94
8.12.1 Company Overview 94
8.12.2 DiaSorin S.p.A Pipeline Products 95
8.12.2.1 DiaSorin S.p.A Pipeline Products By Equipment Type 95
8.12.2.2 DiaSorin S.p.A Pipeline Products By Development Stage 95
8.12.2.3 DiaSorin S.p.A Pipeline Products By Therapy Area 95
8.13 Dade Behring Holdings, Inc. 96
8.13.1 Company Overview 96
8.14 Bio-Rad Laboratories, Inc. 96
8.14.1 Company Overview 96
8.15 bioMerieux S.A. 97
8.15.1 Company Overview 97
8.16 Becton, Dickinson and Company 97
8.16.1 Company Overview 97
8.16.2 Becton, Dickinson and Company Pipeline Products 98
8.16.2.1 Becton, Dickinson and Company Pipeline Products By Equipment Type 98
8.16.2.2 Becton, Dickinson and Company Pipeline Products By Development Stage 99
8.16.2.3 Becton, Dickinson and Company Pipeline Products By Therapy Area 99
8.16.2.4 Becton, Dickinson and Company Pipeline Products By Clinical Trials 100
8.16.2.5 Becton, Dickinson and Company Pipeline Products By News Summary 100
8.17 Beckman Coulter, Inc. 101
8.17.1 Company Overview 101
8.17.2 Beckman Coulter, Inc. Pipeline Products 101
8.17.2.1 Beckman Coulter, Inc. Pipeline Products By Equipment Type 101
8.17.2.2 Beckman Coulter, Inc. Pipeline Products By Development Stage 102
8.17.2.3 Beckman Coulter, Inc. Pipeline Products By Therapy Area 103
8.17.2.4 Beckman Coulter, Inc. Pipeline Products By News Summary 103
8.18 Abbott Laboratories 104
8.18.1 Company Overview 104
8.18.2 Abbott Laboratories Pipeline Products 104
8.18.2.1 Abbott Laboratories Pipeline Products By Equipment Type 104
8.18.2.2 Abbott Laboratories Pipeline Products By Development Stage 104
8.18.2.3 Abbott Laboratories Pipeline Products By Therapy Area 104
8.19 Techno Medica Co., Ltd. 105
8.19.1 Company Overview 105
8.20 Eiken Chemical Co.,Ltd. 105
8.20.1 Company Overview 105
8.20.2 Eiken Chemical Co.,Ltd. Pipeline Products 105
8.20.2.1 Eiken Chemical Co.,Ltd. Pipeline Products By Equipment Type 105
8.20.2.2 Eiken Chemical Co.,Ltd. Pipeline Products By Development Stage 106
8.20.2.3 Eiken Chemical Co.,Ltd. Pipeline Products By Therapy Area 106
9 Financial Deals Landscape 107
9.1 Detailed Deal Summary 107
9.1.1 Acquisition 107
9.1.1.1 Caio Auriemo Completes Sale of Stake in Diagnosticos da America 107
9.1.2 Partnerships 108
9.1.2.1 Accumetrics Enters Into Agreement With Grifols 108
10 Recent Developments 109
10.1 Strategy And Business Planning 109
10.1.1 May 20, 2009: Moksha8, Roche Expands Alliance For Brazilian and Mexican Markets 109
10.1.2 Apr 07, 2009: Covance Announces New Clinical Development Offices In Chile, Peru And Expands Argentina Office 109
10.2 Government and Public Interest 110
10.2.1 Apr 29, 2009: Government Of Canada To Provide Laboratory Testing Support To Government Of Mexico 110
10.3 Other Significant Developments 110
10.3.1 Jul 29, 2009: MedMira Announces New Product Sales In Bulgaria, Chile And Colombia 110
10.3.2 May 28, 2009: Qiagen To Supply Molecular Screening Solutions To Increase Safety Of Blood Donations In Brazil 111
11 Appendix 112
11.1 Global Markets Direct Research Methodology 112
11.2 Secondary Research 113
11.3 Primary Research 113
11.4 Models 114
11.5 Forecasts 114
11.6 Expert Panel Validation 114
11.7 Currency Conversion 115
11.8 Contact Us 116
11.9 Disclaimer 116

1.1 List of Tables
Table 1: In Vitro Diagnostics, South and Central America, Overall Revenue ($ mn), 2000-2015 16
Table 2: South and Central America, In Vitro Diagnostics, Portfolio Analysis, 2000-2015 17
Table 3: In Vitro Diagnostics, South and Central America, Overall Revenue ($ mn), Historic, 2000-2008 19
Table 4: In Vitro Diagnostics, South and Central America, Overall Revenue ($ mn), Forecast, 2008-2015 21
Table 5: In Vitro Diagnostics, South and Central America, Company share by Revenue ($ mn), 2007-2008 22
Table 6: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), 2000-2015 23
Table 7: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Historic, 2000-2008 25
Table 8: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Forecast, 2008-2015 27
Table 9: Clinical Chemistry, Brazil, Distribution Share by Revenue ($mn), 2007-2008 28
Table 10: Genetic Testing, Brazil, Distribution Share by Revenue ($mn), 2007-2008 28
Table 11: Haematology, Brazil, Distribution Share by Revenue ($mn), 2007-2008 29
Table 12: Histology And Cytology, Brazil, Distribution Share by Revenue ($mn), 2007-2008 29
Table 13: Immuno Chemistry, Brazil, Distribution Share by Revenue ($mn), 2007-2008 30
Table 14: Infectious Immunology, Brazil, Distribution Share by Revenue ($mn), 2007-2008 30
Table 15: Microbiology Culture, Brazil, Distribution Share by Revenue ($mn), 2007-2008 31
Table 16: In Vitro Diagnostics, Brazil, Company Share by Revenue ($ mn), 2007-2008 32
Table 17: Clinical Chemistry, Brazil, Company Share by Revenue ($ mn), 2007-2008 33
Table 18: Genetic Testing, Brazil, Company Share by Revenue ($ mn), 2007-2008 34
Table 19: Haematology, Brazil, Company Share by Revenue ($ mn), 2007-2008 35
Table 20: Histology And Cytology, Brazil, Company Share by Revenue ($ mn), 2007-2008 36
Table 21: Immuno Chemistry, Brazil, Company Share by Revenue ($ mn), 2007-2008 38
Table 22: Infectious Immunology, Brazil, Company Share by Revenue ($ mn), 2007-2008 40
Table 23: Microbiology Culture, Brazil, Company Share by Revenue ($ mn), 2007-2008 41
Table 24: In Vitro Diagnostics, Argentina, Overall Revenue ($ mn), 2000-2015 42
Table 25: In Vitro Diagnostics, Argentina, Overall Revenue ($ mn), Historic, 2000-2008 44
Table 26: In Vitro Diagnostics, Argentina, Overall Revenue ($ mn), Forecast, 2008-2015 46
Table 27: Clinical Chemistry, Argentina, Distribution Share by Revenue ($mn), 2007-2008 47
Table 28: Genetic Testing, Argentina, Distribution Share by Revenue ($mn), 2007-2008 47
Table 29: Haematology, Argentina, Distribution Share by Revenue ($mn), 2007-2008 48
Table 30: Histology And Cytology, Argentina, Distribution Share by Revenue ($mn), 2007-2008 48
Table 31: Immuno Chemistry, Argentina, Distribution Share by Revenue ($mn), 2007-2008 49
Table 32: Infectious Immunology, Argentina, Distribution Share by Revenue ($mn), 2007-2008 49
Table 33: Microbiology Culture, Argentina, Distribution Share by Revenue ($mn), 2007-2008 50
Table 34: In Vitro Diagnostics, Argentina, Company Share by Revenue ($ mn), 2007-2008 51
Table 35: Clinical Chemistry, Argentina, Company Share by Revenue ($ mn), 2007-2008 52
Table 36: Genetic Testing, Argentina, Company Share by Revenue ($ mn), 2007-2008 53
Table 37: Haematology, Argentina, Company Share by Revenue ($ mn), 2007-2008 54
Table 38: Histology And Cytology, Argentina, Company Share by Revenue ($ mn), 2007-2008 55
Table 39: Immuno Chemistry, Argentina, Company Share by Revenue ($ mn), 2007-2008 57
Table 40: Infectious Immunology, Argentina, Company Share by Revenue ($ mn), 2007-2008 59
Table 41: Microbiology Culture, Argentina, Company Share by Revenue ($ mn), 2007-2008 60
Table 42: In Vitro Diagnostics, Mexico, Overall Revenue ($ mn), 2000-2015 61
Table 43: Clinical Chemistry, Mexico, Distribution Share by Revenue ($mn), 2007-2008 62
Table 44: Genetic Testing, Mexico, Distribution Share by Revenue ($mn), 2007-2008 62
Table 45: Haematology, Mexico, Distribution Share by Revenue ($mn), 2007-2008 63
Table 46: Histology And Cytology, Mexico, Distribution Share by Revenue ($mn), 2007-2008 63
Table 47: Immuno Chemistry, Mexico, Distribution Share by Revenue ($mn), 2007-2008 64
Table 48: Infectious Immunology, Mexico, Distribution Share by Revenue ($mn), 2007-2008 64
Table 49: Microbiology Culture, Mexico, Distribution Share by Revenue ($mn), 2007-2008 65
Table 50: In Vitro Diagnostics, Mexico, Company Share by Revenue ($ mn), 2007-2008 66
Table 51: Clinical Chemistry, Mexico, Company Share by Revenue ($ mn), 2007-2008 67
Table 52: Genetic Testing, Mexico, Company Share by Revenue ($ mn), 2007-2008 68
Table 53: Haematology, Mexico, Company Share by Revenue ($ mn), 2007-2008 69
Table 54: Histology And Cytology, Mexico, Company Share by Revenue ($ mn), 2007-2008 70
Table 55: Immuno Chemistry, Mexico, Company Share by Revenue ($ mn), 2007-2008 72
Table 56: Infectious Immunology, Mexico, Company Share by Revenue ($ mn), 2007-2008 74
Table 57: Microbiology Culture, Mexico, Company Share by Revenue ($ mn), 2007-2008 75
Table 58: Sysmex Corporation Pipeline Products by Equipment Type 76
Table 59: Sysmex Corporation Pipeline Products By Development Stage 76
Table 60: Sysmex Corporation Pipeline Products By Therapy Area 77
Table 61: Sysmex Corporation Pipeline Products By News Summary 77
Table 62: Qiagen N.V. Pipeline Products by Equipment Type 79
Table 63: Qiagen N.V. Pipeline Products By Development Stage 79
Table 64: Qiagen N.V. Pipeline Products By Therapy Area 80
Table 65: Qiagen N.V. Pipeline Products By News Summary 80
Table 66: Phadia AB Pipeline Products by Equipment Type 81
Table 67: Phadia AB Pipeline Products By Development Stage 81
Table 68: Phadia AB Pipeline Products By Therapy Area 82
Table 69: Phadia AB Pipeline Products By News Summary 82
Table 70: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 83
Table 71: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage 84
Table 72: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area 84
Table 73: Inverness Medical Innovations, Inc. Pipeline Products by Equipment Type 86
Table 74: Inverness Medical Innovations, Inc. Pipeline Products By Development Stage 86
Table 75: Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area 87
Table 76: Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials 87
Table 77: Inverness Medical Innovations, Inc. Pipeline Products By News Summary 87
Table 78: Hologic, Inc. Pipeline Products by Equipment Type 88
Table 79: Hologic, Inc. Pipeline Products By Development Stage 89
Table 80: Hologic, Inc. Pipeline Products By Therapy Area 89
Table 81: Hologic, Inc. Pipeline Products By Clinical Trials 89
Table 82: Hologic, Inc. Pipeline Products By News Summary 90
Table 83: Gen-Probe Incorporated Pipeline Products by Equipment Type 91
Table 84: Gen-Probe Incorporated Pipeline Products By Development Stage 92
Table 85: Gen-Probe Incorporated Pipeline Products By Therapy Area 92
Table 86: Gen-Probe Incorporated Pipeline Products By Clinical Trials 92
Table 87: Gen-Probe Incorporated Pipeline Products By News Summary 93
Table 88: DiaSorin S.p.A Pipeline Products by Equipment Type 95
Table 89: DiaSorin S.p.A Pipeline Products By Development Stage 95
Table 90: DiaSorin S.p.A Pipeline Products By Therapy Area 95
Table 91: Becton, Dickinson and Company Pipeline Products by Equipment Type 98
Table 92: Becton, Dickinson and Company Pipeline Products By Development Stage 99
Table 93: Becton, Dickinson and Company Pipeline Products By Therapy Area 99
Table 94: Becton, Dickinson and Company Pipeline Products By Clinical Trials 100
Table 95: Becton, Dickinson and Company Pipeline Products By News Summary 100
Table 96: Beckman Coulter, Inc. Pipeline Products by Equipment Type 101
Table 97: Beckman Coulter, Inc. Pipeline Products By Development Stage 102
Table 98: Beckman Coulter, Inc. Pipeline Products By Therapy Area 103
Table 99: Beckman Coulter, Inc. Pipeline Products By News Summary 103
Table 100: Abbott Laboratories Pipeline Products by Equipment Type 104
Table 101: Abbott Laboratories Pipeline Products By Development Stage 104
Table 102: Abbott Laboratories Pipeline Products By Therapy Area 104
Table 103: Eiken Chemical Co.,Ltd. Pipeline Products by Equipment Type 105
Table 104: Eiken Chemical Co.,Ltd. Pipeline Products By Development Stage 106
Table 105: Eiken Chemical Co.,Ltd. Pipeline Products By Therapy Area 106
Table 106: Caio Auriemo Completes Sale Of Stake In Diagnosticos da America 107
Table 107: Accumetrics Enters Into Agreement With Grifols 108
Table 108: USD to Local Currency, Average Exchange Rate 2008 115

1.2 List of Figures
Figure 1: In Vitro Diagnostics, South and Central America, Overall Revenue ($ mn), 2000-2015 16
Figure 2: South and Central America, In Vitro Diagnostics, Portfolio Analysis, 2000-2015 17
Figure 3: In Vitro Diagnostics, South and Central America, Overall Revenue ($ mn), Historic, 2000-2008 18
Figure 4: In Vitro Diagnostics, South and Central America, Overall Revenue ($ mn), Forecast, 2008-2015 20
Figure 5: In Vitro Diagnostics, South and Central America, Company share (%), 2008 22
Figure 6: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), 2000-2015 23
Figure 7: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Historic, 2000-2008 24
Figure 8: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Forecast, 2008-2015 26
Figure 9: In Vitro Diagnostics, Brazil, Company Share (%), 2008 32
Figure 10: Clinical Chemistry, Brazil, Company Share (%), 2008 33
Figure 11: Genetic Testing, Brazil, Company Share (%), 2008 34
Figure 12: Haematology, Brazil, Company Share (%), 2008 35
Figure 13: Histology And Cytology, Brazil, Company Share (%), 2008 36
Figure 14: Immuno Chemistry, Brazil, Company Share (%), 2008 37
Figure 15: Infectious Immunology, Brazil, Company Share (%), 2008 39
Figure 16: Microbiology Culture, Brazil, Company Share (%), 2008 41
Figure 17: In Vitro Diagnostics, Argentina, Overall Revenue ($ mn), 2000-2015 42
Figure 18: In Vitro Diagnostics, Argentina, Overall Revenue ($ mn), Historic, 2000-2008 43
Figure 19: In Vitro Diagnostics, Argentina, Overall Revenue ($ mn), Forecast, 2008-2015 45
Figure 20: In Vitro Diagnostics, Argentina, Company Share (%), 2008 51
Figure 21: Clinical Chemistry, Argentina, Company Share (%), 2008 52
Figure 22: Genetic Testing, Argentina, Company Share (%), 2008 53
Figure 23: Haematology, Argentina, Company Share (%), 2008 54
Figure 24: Histology And Cytology, Argentina, Company Share (%), 2008 55
Figure 25: Immuno Chemistry, Argentina, Company Share (%), 2008 56
Figure 26: Infectious Immunology, Argentina, Company Share (%), 2008 58
Figure 27: Microbiology Culture, Argentina, Company Share (%), 2008 60
Figure 28: In Vitro Diagnostics, Mexico, Overall Revenue ($ mn), 2000-2015 61
Figure 29: In Vitro Diagnostics, Mexico, Company Share (%), 2008 66
Figure 30: Clinical Chemistry, Mexico, Company Share (%), 2008 67
Figure 31: Genetic Testing, Mexico, Company Share (%), 2008 68
Figure 32: Haematology, Mexico, Company Share (%), 2008 69
Figure 33: Histology And Cytology, Mexico, Company Share (%), 2008 70
Figure 34: Immuno Chemistry, Mexico, Company Share (%), 2008 71
Figure 35: Infectious Immunology, Mexico, Company Share (%), 2008 73
Figure 36: Microbiology Culture, Mexico, Company Share (%), 2008 75
Figure 37: Global Markets Direct Methodology 112

Visitor Comments

All Comments

Change Currency

GBP

EURO

USD

Last Viewed

South and Central America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

South America automotive review – forecasts to 2014

South African Express Market Overview

South Africa - Telecoms, Mobile and Broadband

Healthcare and Medical Company Profiles

Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

South and Central America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Select License Type

Speak to an Advisor

Select License Type

Table of Contents

Visitor Comments

Change Currency

Last Viewed

Healthcare and Medical Company Profiles

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel